Livzon Pharmaceutical Group Inc.’s Net Profit Rose 0.4% in First Quarter of 2023

Livzon Pharmaceutical Group Inc. (丽珠医药集团股份有限公司) (000513.SZ) reported a net profit of 613.9 million yuan in the first quarter of 2023, up 0.4% year-on-year.

Meanwhile, the company posted 3.4 billion yuan in revenue, down 1.9% year-on-year.

At the end of the reporting period, it had 25.6 billion yuan in total assets and 10.2 billion yuan in total liabilities, with a liability-to-asset ratio of 39.8%.